arginyl-glycyl-aspartic acid has been researched along with Carcinoma, Squamous Cell in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (33.33) | 18.2507 |
| 2000's | 3 (16.67) | 29.6817 |
| 2010's | 9 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jin, Y; Lv, L; Ning, SX; Wang, JH; Xiao, R | 1 |
| Kessler, H; Nieberler, M; Reichart, F; Reuning, U; Weirich, G; Wolff, KD | 1 |
| Abiraj, K; Boerman, OC; Bussink, J; Frielink, C; Oyen, WJ; Terry, SY; van Dijk, LK | 1 |
| Barnucz, E; Braun, F; Fani, M; Lassmann, S; Maecke, HR; Rylova, SN; Weber, WA; Werner, M | 1 |
| Hao, H; Hong, T; Kai, Y; Yunlong, B | 1 |
| Jiang, J; Lv, L; Lv, M; Shao, F; Wang, J; Wang, Y; Zheng, Y | 1 |
| El-Sayed, MA; Kang, B; Mackey, MA | 1 |
| Chen, X; Kim, K; Lee, S; Lin, X; Ma, Y; Niu, G; Xie, J; Zhu, L | 1 |
| Baechler, S; Buchegger, F; Dunet, V; Kosinski, M; Poitry-Yamate, C; Prior, JO; Rüegg, C; Viertl, D | 1 |
| Dehari, H; Hamada, H; Ito, Y; Kobune, M; Kohama, G; Nakamura, T; Sasaki, K; Yonekura, N | 1 |
| Dazin, P; Kapila, Y; Lu, H; Zhang, Y | 1 |
| Bock, M; Eisenhut, M; Jugold, M; Kiessling, F; Lammers, T; Morgenstern, B; Mueller, MM; Semmler, W; Woenne, EC; Zentgraf, H; Zhang, C | 1 |
| Imai, K; Kawahara, E; Kumagai, S; Nakanishi, I; Yamamoto, E | 1 |
| Dixit, VM; Mansfield, PJ; Suchard, SJ; Yabkowitz, R | 1 |
| Felding-Habermann, B; Germer, M; Goodman, S; Kanse, SM; Kirkegaard, T; Kjøller, L; Preissner, KT | 1 |
| Blackwell, JL; Bucy, RP; Carroll, WR; Curiel, DT; Dmitriev, I; Douglas, JT; Kasono, K; Krasnykh, V; Kropf, DA; Peters, GE; Reynolds, P; Strong, TV | 1 |
| Giga-Hama, Y; Goto, H; Isoai, A; Kumagai, H; Ueno, Y | 1 |
| Dixit, VM; Yabkowitz, R | 1 |
18 other study(ies) available for arginyl-glycyl-aspartic acid and Carcinoma, Squamous Cell
| Article | Year |
|---|---|
The Anti-tumor Activity and Mechanisms of rLj-RGD3 on Human Laryngeal Squamous Carcinoma Hep2 Cells.
Topics: Animals; Antineoplastic Agents; Apoptosis; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Laryngeal Neoplasms; Liver Neoplasms, Experimental; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Oligopeptides; Structure-Activity Relationship | 2019 |
Fluorescence imaging of invasive head and neck carcinoma cells with integrin αvβ6-targeting RGD-peptides: an approach to a fluorescence-assisted intraoperative cytological assessment of bony resection margins.
Topics: Adult; Aged; Aged, 80 and over; Antigens, Neoplasm; Carcinoma, Squamous Cell; Cell Line, Tumor; Female; Head and Neck Neoplasms; Humans; Integrins; Male; Middle Aged; Oligopeptides; Optical Imaging | 2018 |
Imaging integrin αvβ3 on blood vessels with 111In-RGD2 in head and neck tumor xenografts.
Topics: Animals; Blood Vessels; Carcinoma, Squamous Cell; Cell Line, Tumor; Female; Head and Neck Neoplasms; Immunohistochemistry; Indium Radioisotopes; Integrin alphaVbeta3; Mice; Mice, Inbred BALB C; Neoplasm Transplantation; Neovascularization, Pathologic; Oligopeptides; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 2014 |
Does imaging αvβ3 integrin expression with PET detect changes in angiogenesis during bevacizumab therapy?
Topics: Acetates; Algorithms; Angiogenesis Inhibitors; Animals; Antibodies, Monoclonal, Humanized; Bevacizumab; Carcinoma, Squamous Cell; Cell Line, Tumor; Female; Gallium Radioisotopes; Heterocyclic Compounds, 1-Ring; Humans; Integrin alphaVbeta3; Mice; Mice, Inbred BALB C; Mice, Nude; Microcirculation; Necrosis; Neoplasm Transplantation; Neovascularization, Pathologic; Oligopeptides; Peptides; Permeability; Positron-Emission Tomography; Time Factors | 2014 |
[In situ visual imaging of oral squamous cell carcinoma in mice by using near-infrared quantum dots conjugated with arginine-glycine-aspartic acid peptide fluorescent probes].
Topics: Animals; Arginine; Aspartic Acid; Carcinoma, Squamous Cell; Cell Line, Tumor; Fluorescent Dyes; Glycine; Humans; Mice; Mice, Nude; Mouth Neoplasms; Oligopeptides; Peptides; Quantum Dots | 2014 |
The anti-tumour activity of rLj-RGD4, an RGD toxin protein from Lampetra japonica, on human laryngeal squamous carcinoma Hep-2 cells in nude mice.
Topics: Amino Acid Motifs; Angiogenesis Inhibitors; Animals; Apoptosis; Body Weight; Carcinoma, Squamous Cell; Cell Line, Tumor; Fish Proteins; Fish Venoms; Gene Expression Regulation, Neoplastic; Head and Neck Neoplasms; Humans; Lampreys; Laryngeal Neoplasms; Marine Toxins; Mice, Nude; Microvessels; Oligopeptides; Random Allocation; Recombinant Proteins; Squamous Cell Carcinoma of Head and Neck; Survival Analysis; Tumor Burden; Xenograft Model Antitumor Assays | 2015 |
Nuclear targeting of gold nanoparticles in cancer cells induces DNA damage, causing cytokinesis arrest and apoptosis.
Topics: Amino Acid Sequence; Apoptosis; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Nucleus; Cytokinesis; DNA Damage; Gold; Humans; Metal Nanoparticles; Mouth Neoplasms; Oligopeptides; Peptides | 2010 |
Hybrid ferritin nanoparticles as activatable probes for tumor imaging.
Topics: Amino Acid Sequence; Animals; Carcinoma, Squamous Cell; Diagnostic Imaging; Ferritins; Fluorescent Dyes; Head and Neck Neoplasms; Hydrogen-Ion Concentration; Matrix Metalloproteinase 13; Mice; Nanoparticles; Oligopeptides; Spectrometry, Fluorescence; Transplantation, Heterologous | 2011 |
68Ga-NODAGA-RGDyK for αvβ3 integrin PET imaging. Preclinical investigation and dosimetry.
Topics: Animals; Body Burden; Carcinoma, Squamous Cell; Cell Line, Tumor; Drug Evaluation, Preclinical; Female; Gallium Radioisotopes; Heterocyclic Compounds; Heterocyclic Compounds, 1-Ring; Humans; Integrin alphaVbeta3; Metabolic Clearance Rate; Mice; Mice, Inbred ICR; Oligopeptides; Organ Specificity; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Whole-Body Counting | 2011 |
Enhanced antitumor effect of RGD fiber-modified adenovirus for gene therapy of oral cancer.
Topics: Adenoviridae; Animals; Carcinoma, Squamous Cell; Coxsackie and Adenovirus Receptor-Like Membrane Protein; DNA Primers; Female; Flow Cytometry; Gene Transfer Techniques; Genetic Therapy; Genetic Vectors; Humans; Interleukin-2; Mice; Mice, Inbred BALB C; Mice, Nude; Mouth Neoplasms; Oligopeptides; Polymerase Chain Reaction; Receptors, Virus; Recombinant Proteins; Tumor Cells, Cultured | 2003 |
Squamous cell carcinoma cell aggregates escape suspension-induced, p53-mediated anoikis: fibronectin and integrin alphav mediate survival signals through focal adhesion kinase.
Topics: Animals; Anoikis; Antineoplastic Agents; Carcinoma, Squamous Cell; Cell Aggregation; Cell Culture Techniques; Cell Line, Tumor; Cell Survival; Extracellular Matrix; Fibronectins; Focal Adhesion Kinase 1; Focal Adhesion Protein-Tyrosine Kinases; Humans; Integrin alphaV; Mouth Neoplasms; Oligonucleotides, Antisense; Oligopeptides; Phenotype; Protein-Tyrosine Kinases; Tumor Suppressor Protein p53 | 2004 |
Specific targeting of tumor angiogenesis by RGD-conjugated ultrasmall superparamagnetic iron oxide particles using a clinical 1.5-T magnetic resonance scanner.
Topics: Animals; Carcinoma, Squamous Cell; Cells, Cultured; Endothelial Cells; Ferric Compounds; Humans; Integrin alphaVbeta3; Magnetic Resonance Imaging; Mice; Mice, Nude; Neoplasms, Experimental; Neovascularization, Pathologic; Oligopeptides; Particle Size; Propylamines; Silanes | 2007 |
Inhibitory effects of adhesion oligopeptides on the invasion of squamous carcinoma cells with special reference to implication of alpha v integrins.
Topics: Amino Acid Sequence; Basement Membrane; Carcinoma, Squamous Cell; Cell Adhesion; Collagen; Extracellular Matrix Proteins; Fibronectins; Glycoproteins; Humans; Integrins; Laminin; Microscopy, Fluorescence; Molecular Sequence Data; Neoplasm Invasiveness; Oligopeptides; Receptors, Fibronectin; Tumor Cells, Cultured; Vitronectin | 1995 |
Motility of human carcinoma cells in response to thrombospondin: relationship to metastatic potential and thrombospondin structural domains.
Topics: Carcinoma, Squamous Cell; Cell Movement; Chemotaxis; Heparin; Humans; In Vitro Techniques; Integrins; Neoplasm Metastasis; Oligopeptides; Peptide Fragments; Platelet Membrane Glycoproteins; Structure-Activity Relationship; Thrombospondins; Tumor Cells, Cultured | 1993 |
Kinetic analysis of integrin-dependent cell adhesion on vitronectin--the inhibitory potential of plasminogen activator inhibitor-1 and RGD peptides.
Topics: Amino Acid Sequence; Antigens, CD; Binding Sites; Carcinoma, Squamous Cell; Cell Adhesion; Humans; Integrin alphaV; Kinetics; Oligopeptides; Plasminogen Activator Inhibitor 1; Protein Conformation; Thrombin; Tumor Cells, Cultured; Urokinase-Type Plasminogen Activator; Vitronectin | 1998 |
Selective gene delivery to head and neck cancer cells via an integrin targeted adenoviral vector.
Topics: Adenoviridae; Biomarkers, Tumor; Carcinoma, Squamous Cell; Coxsackie and Adenovirus Receptor-Like Membrane Protein; Genetic Therapy; Genetic Vectors; Head and Neck Neoplasms; HeLa Cells; Humans; Integrin alpha3beta1; Integrins; Oligopeptides; Receptors, Collagen; Receptors, Virus; Tumor Cells, Cultured | 1999 |
A novel Arg-Gly-Asp containing peptide specific for platelet aggregation and its effect on tumor metastasis: a possible mechanism of RGD peptide-mediated inhibition of tumor metastasis.
Topics: Animals; Anticarcinogenic Agents; Arginine; Aspartic Acid; Carcinoma, Squamous Cell; Cell Adhesion; Collagen; Female; Fibronectins; Glycine; Glycoproteins; Lung Neoplasms; Mice; Mice, Inbred C3H; Neoplasm Metastasis; Oligopeptides; Peptides, Cyclic; Platelet Aggregation; Protein Binding; Vitronectin | 1992 |
Human carcinoma cells express receptors for distinct domains of thrombospondin.
Topics: Binding Sites; Carcinoma, Squamous Cell; CD36 Antigens; Dose-Response Relationship, Drug; Heparin; Humans; Oligopeptides; Platelet Membrane Glycoproteins; Receptors, Cytoadhesin; Thrombospondins; Tumor Cells, Cultured | 1991 |